Abstract
Duration of treatment with cemiplimab in advanced cutaneous squamous cell carcinoma in complete response: Real-life study.
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Journal of the European Academy of Dermatology and Venereology : JEADV
Paper Title
Journal
Date